GeekWire
Menu
  • Home
  • News
    • Amazon
    • Civic presented by Microsoft
    • Geek Life presented by Network of Giving
    • Health/Life Sciences
    • Microsoft
    • Podcasts
    • Space
    • Startups
    • Sustainability
    • Tech Moves
    • Bot or Not
    • GeekWire on the Road: Spokane
    • Microsoft at 50 presented by Accenture
    • Tech Vets presented by Northern Trust
  • GeekWork
    • GeekWork Recruiting
    • Job Board
  • Events
    • Community Calendar
    • GeekWire Events
  • Lists
    • Amazon Office Buildings
    • GeekWire 200 presented by JPMorganChase
    • GeekWire Startup List
    • GeekWire Startup Resources
    • GeekWire Startup Spaces
    • Layoff Tracker
    • M&As and IPOs
    • Northwest Women VC & Angel Investor List
    • Recent Fundings
    • Seattle Engineering Outposts
    • Venture Capital Directory
  • Members
    • Health Benefits
    • Memberships
  • Studios
    • GeekWire Studios: Let Us Tell Your Story
    • Nebius at NVIDIA GTC 2025 sponsored by Nebius
    • AWS Marketplace Seller Conference 2024 sponsored by AWS
    • AWS Summit: New York Partner Spotlights sponsored by AWS
    • Does Compute presented by Carnegie Mellon University
    • Guide to re:Invent sponsored by AWS
    • Money Hacks presented by BECU
    • Tech Connect at Dreamforce 2024 sponsored by RSM US LLP
    • Uncommon Thinkers Welcome sponsored by Greater Seattle Partners
    • Zuper at Inbound sponsored by Zuper
  • About
    • About GeekWire
    • Advertise
    • Contact Us
    • Email Newsletters
    • Reprints & Permissions
    • Sponsors
  • Podcast
  • LinkedIn
  • Newsletter
  • News Tips

What happens here matters everywhere.

  • Podcast
  • LinkedIn
  • Newsletter
  • News Tips
  • Amazon
  • Microsoft
  • Startups
  • AI
  • Science
  • Tech Moves
  • Sustainability
  • Civic
  • Geek Life

Omeros

Tech Moves: Microsoft CMO joins 3D printing startup board; Omeros names medical chief

— Somerville, Mass.-based 3D printer company Formlabs appointed Microsoft Chief Marketing Officer Chris Capossela to its board of directors. Capossela has spent more than… Read More

Omeros sells eye surgery product to Rayner for $126M in cash

Seattle biotech Omeros completed a deal Thursday to sell Omidria, a product used in eye surgery, to Rayner Surgical Group.… Read More

Shares of Seattle biotech firm Omeros spike after reporting COVID-19 treatment results

Omeros stock shot up more than 60% after the Seattle-based biotech company reported promising results from its COVID-19 drug treatment.… Read More

Biotech company Omeros and former exec battling in court over non-compete deal and bonuses

Omeros, one of Seattle’s biggest biotech companies, is in the midst of a contentious legal battle with its former chief… Read More

Why Seattle’s Omeros continues to be dogged by questions over its next big drug

Omeros, one of Seattle’s biggest biotech companies, may have its hands on a lucrative new drug — but questions about… Read More

Omeros looks to raise $70M in stock offering to fuel drug development pipeline

The Omeros Corporation, one of Seattle’s biggest biotech companies, is looking to raise approximately $70 million in a follow-on public… Read More

Latest Stories

    Read All Stories

    GeekWire Newsletters

    Subscribe to GeekWire's free newsletters to catch every headline

    Send Us a Tip

    Have a scoop that you'd like GeekWire to cover? Let us know.

    Send Us a Tip

    A Word From Our Sponsors

    About

    • About GeekWire
    • Contact Us
    • Partner With Us
    • Become a GeekWire Member
    • Send Us a Tip
    • Join Our Startup List
    • Reprints and Permissions

    Follow

    • Facebook
    • X
    • LinkedIn
    • Instagram
    • RSS Feed
    • Podcast
    • YouTube
    • Bluesky

    GeekWire Newsletters

    Catch every headline in your inbox

    Read GeekWire

    • Apple News
    • Google News

    Legal

    • Privacy Policy
    • Terms of Use
    • Sponsored Content Policy
    Return to Top of Page
    © 2011-2025 GeekWire, LLC
    Do Not Sell or Share My Personal information
    Limit the Use Of My Sensitive Personal Information
    Consent Preferences